FYI from the NHLBI Index
May 2011: Vol. 12, Issue 1
NHLBI Will Host the 12th Annual PIO Meeting
The NHLBI will hold its Twelfth Annual Public Interest Organization (PIO) meeting on May 23–24, 2011, at the Bethesda Marriott on
Pooks Hill Road in Bethesda, Maryland. PIO attendees of the previous annual meetings have praised the events for providing unique
opportunities to interact with other PIO representatives, to learn more about the NIH and the NHLBI, and to meet NIH and NHLBI leadership
as well as NHLBI staff members.
The upcoming meeting, with its focus on timely, important topics, promises not to disappoint. This year’s meeting program will
again encourage significant networking time with members of fellow PIOs as well as with NHLBI staff.
The meeting will begin Monday afternoon, May 23, with registration at 4 pm. At 5 pm, opening remarks will be followed by the keynote
address delivered by Dr. Lawrence A. Tabak, Deputy Director, NIH.
On Tuesday, May 24, registration resumes at 7:30 am.
Tuesday’s program will begin at 8:30 am with a presentation by Dr. Susan B. Shurin, Acting Director, NHLBI, and will feature an
array of speakers from PIOs, the NHLBI, and the NIH.
Following Dr. Shurin’s presentation, PIO representatives will have an opportunity to meet NHLBI staff members who have expertise
in heart development and diseases, vascular diseases, lung diseases, airway diseases, blood diseases and resources, and sleep and
sleep disorders. This portion of the meeting has been very well received in the past.
After lunch, the meeting will continue with presentations about the NIH Undiagnosed Diseases Program offered by Dr. Cynthia Tifft,
Deputy Clinical Director, National Human Genome Research Institute, NIH, and Dr. Robert Balaban, Scientific Director, NHLBI.
A session on Dietary Supplements will be presented by Dr. Paul Coates, Director, Office of Dietary Supplements, NIH, and Ms. Caroline Kruse,
Executive Director, Platelet Disorder Support Association.
The concluding session will focus on Collaboration, Resources, and Information Sharing and will be presented by Mr. James O’Leary, Chief
Innovation Officer, Genetic Alliance, Dr. Stephen Groft, Director, Office of Rare Diseases Research, NIH, and Ms. Audrey Gordon, Executive
Director, Progeria Research Foundation.
[Table of Contents]
Please send us your feedback, comments, and questions by using the appropriate link on the page, Contact the NHLBI.
Note to users of screen readers and other assistive technologies: please report your problems here.